Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.
Begcevic I, Tsolaki M, Brinc D, Brown M, Martinez-Morillo E, Lazarou I, Kozori M, Tagaraki F, Nenopoulou S, Gkioka M, Lazarou E, Lim B, Batruch I, Diamandis EP.
Begcevic I, et al. Among authors: gkioka m.
F1000Res. 2018 Jul 5;7:1012. doi: 10.12688/f1000research.15095.1. eCollection 2018.
F1000Res. 2018.
PMID: 30191060
Free PMC article.
Clinical Trial.